Electroacupuncture Relieves LPS-Induced Depression-Like Behaviour in Rats Through IDO-Mediated Tryptophan-Degrading Pathway
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Neuroinflammation is an important pathological mechanism of depression that leads to an increase in indoleamine-2,3-dioxygenase (IDO) activity and NMDAR activation. This study aimed to observe the effects of electroacupuncture on depression-like behaviour in lipopolysaccharide (LPS)-treated rats and the underlying mechanism. METHODS: Wistar rats were intraperitoneally administered LPS (0.5 mg/kg) for 7 consecutive days to establish a depression model. Electroacupuncture treatment was administered 1 hour after daily LPS injection. The open field test (OFT), forced swimming test (FST), and sucrose preference test (SPT) were used to evaluate the depressive-like behaviours. IL-1β, IL-6, and TNF-α levels were determined by enzyme-linked immunosorbent assay (ELISA); Trp, 5-hydroxytryptamine (5-HT), kynurenine (Kyn) and quinolinic acid (Quin) were detected by ultra-high-performance liquid chromatography-tandem mass spectrometry; and N-methyl-D-aspartate receptor (NMDAR) protein and mRNA were assessed by Western blot and real-time qPCR. RESULTS: The results showed that electroacupuncture treatment successfully corrected LPS-induced depressive-like behaviour, reduced the inflammatory factor (IL-1β, IL-6 and TNF-α) levels in the blood and hippocampus, prevented IDO over-activation and recovered NR2B expression after challenge by LPS. CONCLUSION: Electroacupuncture treatment provided protection against LPS-induced depressive-like behaviour, and the associated mechanisms may be related to inhibiting the inflammatory response, regulating the IDO-mediated tryptophan-degrading pathway, and inhibiting NR2B activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Peripheral and central inflammation can both stimulate the KYN pathway and trigger TRP metabolism and subsequent synthesis of various TRYCATs, including the toxic NMDAR activator QUIN, 246”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [246]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Malhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644
Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Kim, Y.-K., Na, K.-S., Myint, A.-M., & Leonard, B. E. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.008 · Cited by 620
Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression
Cui, Y., Yang, Y., Ni, Z., Dong, Y., Cai, G., Foncelle, A., Ma, S., Sang, K., Tang, S., Li, Y., et al. (2018) · Nature · doi:10.1038/nature25752 · Cited by 597
Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders: A Nationwide Study
Benros, M. E., Waltoft, B. L., Nordentoft, M., Østergaard, S. D., Eaton, W. W., Krogh, J., & Mortensen, P. B. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1111 · Cited by 572
Impact of major depression on chronic medical illness
Katon, W., & Ciechanowski, P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00313-6 · Cited by 485
What does plasma CRP tell us about peripheral and central inflammation in depression?
Felger, J. C., Haroon, E., Patel, T. A., Goldsmith, D. R., Wommack, E. C., Woolwine, B. J., Le, N.-A., Feinberg, R., Tansey, M. G., & Miller, A. H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0096-3 · Cited by 448
Structure and Function of Glutamate Receptor Ion Channels
Mayer, M. L., & Armstrong, N. (2004) · Annual Review of Physiology · doi:10.1146/annurev.physiol.66.050802.084104 · Cited by 413
Lovelace, M. D., Varney, B., Sundaram, G., Lennon, M. J., Lim, C. K., Jacobs, K., Guillemin, G. J., & Brew, B. J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.024 · Cited by 393
Interleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis
Zunszain, P. A., Anacker, C., Cattaneo, A., Choudhury, S., Musaelyan, K., Myint, A. M., Thuret, S., Price, J., & Pariante, C. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.277 · Cited by 388
Malhi Gin, S., & John, M. J. (2018) · The Lancet · Cited by 332
Smith, C. A., Hay, P. P., & MacPherson, H. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004046.pub3 · Cited by 323
Structure, Function, and Pharmacology of NMDA Receptor Channels
VYKLICKY, V., KORINEK, M., SMEJKALOVA, T., BALIK, A., KRAUSOVA, B., KANIAKOVA, M., LICHNEROVA, K., CERNY, J., KRUSEK, J., DITTERT, I., et al. (2014) · Physiological Research · doi:10.33549/physiolres.932678 · Cited by 321
Kynurenine pathway in depression: a systematic review and meta-analysis
Ogyu, K., Kubo, K., Noda, Y., Iwata, Y., Tsugawa, S., Omura, Y., Wada, M., Tarumi, R., Plitman, E., Moriguchi, S., et al. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.023 · Cited by 301
Sex differences in glutamate receptor gene expression in major depression and suicide
Gray, A. L., Hyde, T. M., Deep-Soboslay, A., Kleinman, J. E., & Sodhi, M. S. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.91 · Cited by 250
Wong, J.-M. T., Malec, P. A., Mabrouk, O. S., Ro, J., Dus, M., & Kennedy, R. T. (2016) · Journal of Chromatography A · doi:10.1016/j.chroma.2016.04.006 · Cited by 248
Mendlewicz, J., Kriwin, P., Oswald, P., Souery, D., Alboni, S., & Brunello, N. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200607000-00005 · Cited by 229
Oxenkrug, G. F. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05356.x · Cited by 221
Vanhoutte, P., & Bading, H. (2003) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(03)00073-4 · Cited by 210
Parrott, J. M., Redus, L., Santana-Coelho, D., Morales, J., Gao, X., & O'Connor, J. C. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.200 · Cited by 174
Acupuncture for Depression: A Systematic Review and Meta-Analysis
Armour, M., Smith, C. A., Wang, L., Naidoo, D., Yang, G., MacPherson, H., Lee, M. S., & Hay, P. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081140 · Cited by 161
Altered neuro-inflammatory gene expression in hippocampus in major depressive disorder
Mahajan, G. J., Vallender, E. J., Garrett, M. R., Challagundla, L., Overholser, J. C., Jurjus, G., Dieter, L., Syed, M., Romero, D. G., Benghuzzi, H., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.017 · Cited by 159
Song, Q., Fan, C., Wang, P., Li, Y., Yang, M., & Yu, S. Y. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1377-0 · Cited by 127
Gibb, J., Hayley, S. P., Gandhi, R., Poulter, M. O., & Anisman, H. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.12.001 · Cited by 121
A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase
Davies, Christmas, D., & Potokar, J. (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s17573 · Cited by 119 · cited 1×
“responsible for tryptophan degradation along the kynurenine pathway.(16) Excessive production of proinflammatory cyto-”
BackgroundThe Role of Indoleamine 2,3-Dioxygenase in a Mouse Model of Neuroinflammation-Induced Depression
Dobos, N., de Vries, E. F. J., Kema, I. P., Patas, K., Prins, M., Nijholt, I. M., Dierckx, R. A., Korf, J., den Boer, J. A., Luiten, P. G. M., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-111097 · Cited by 118
The possible role of the kynurenine pathway in adolescent depression with melancholic features
Gabbay, V., Klein, R. G., Katz, Y., Mendoza, S., Guttman, L. E., Alonso, C. M., Babb, J. S., Hirsch, G. S., & Liebes, L. (2010) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2010.02245.x · Cited by 115
The effects of curcumin on depressive-like behavior in mice after lipopolysaccharide administration
Wang, Z., Zhang, Q., Yuan, L., Wang, S., Liu, L., Yang, X., Li, G., & Liu, D. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.018 · Cited by 107
Yue, N., Li, B., Yang, L., Han, Q.-Q., Huang, H.-J., Wang, Y.-L., Wang, J., Yu, R., Wu, G.-C., Liu, Q., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00149 · Cited by 100
Uncoupling DAPK1 from NMDA receptor GluN2B subunit exerts rapid antidepressant-like effects
Li, S.-X., Han, Y., Xu, L.-Z., Yuan, K., Zhang, R.-X., Sun, C.-Y., Xu, D.-F., Yuan, M., Deng, J.-H., Meng, S.-Q., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.85 · Cited by 98
Messaoud, A., Mensi, R., Douki, W., Neffati, F., Najjar, M. F., Gobbi, G., Valtorta, F., Gaha, L., & Comai, S. (2019) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1468031 · Cited by 96
Tu, C., MacDonald, I. J., & Chen, Y. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00014 · Cited by 92
Amidfar, M., Woelfer, M., Réus, G. Z., Quevedo, J., Walter, M., & Kim, Y.-K. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109668 · Cited by 90
Doolin, K., Allers, K. A., Pleiner, S., Liesener, A., Farrell, C., Tozzi, L., O’Hanlon, E., Roddy, D., Frodl, T., Harkin, A., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.019 · Cited by 89
Rush, G., O’Donovan, A., Nagle, L., Conway, C., McCrohan, A., O’Farrelly, C., Lucey, J. V., & Malone, K. M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.035 · Cited by 86
Voss, O. H., Murakami, Y., Pena, M. Y., Lee, H.-N., Tian, L., Margulies, D. H., Street, J. M., Yuen, P. S. T., Qi, C.-F., Krzewski, K., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.005 · Cited by 77
Potential antiinflammatory effects of acupuncture in a chronic stress model of depression in rats
Lü, J., Shao, R.-H., Hu, L., Tu, Y., & Guo, J. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.02.040 · Cited by 71
Su, K.-P., Lai, H.-C., Peng, C.-Y., Su, W.-P., Chang, J. P.-C., & Pariante, C. M. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.04.032 · Cited by 68
Zhao, B., Li, Z., Wang, Y., Ma, X., Wang, X., Wang, X., Liang, Y., Yang, X., Sun, Y., Meng, S., et al. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.03.015 · Cited by 66
Changes in proinflammatory cytokines and white matter in chronically stressed rats
Xu, H., Yang, P., Gao, Z., Zhang, H., Fang, Z., Wu, C., & Huang, Q.-J. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s78131 · Cited by 61
Glycyrrhizic acid ameliorates the kynurenine pathway in association with its antidepressant effect
Wang, B., Lian, Y.-J., Dong, X., Peng, W., Liu, L.-L., Su, W.-J., Gong, H., Zhang, T., Jiang, C.-L., Li, J.-S., et al. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.01.024 · Cited by 61
Glutamate Transporters in Hippocampal LTD/LTP: Not Just Prevention of Excitotoxicity
Gonçalves-Ribeiro, J., Pina, C. C., Sebastião, A. M., & Vaz, S. H. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00357 · Cited by 61
Han, Y.-G., Qin, X., Zhang, T., Lei, M., Sun, F.-Y., Sun, J.-J., & Yuan, W.-F. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.003 · Cited by 60
Dong, Y., Kalueff, A. V., & Song, C. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.03.005 · Cited by 58
Depression Risk in Patients with Rheumatoid Arthritis in the United Kingdom
Jacob, L., Rockel, T., & Kostev, K. (2017) · Rheumatology and Therapy · doi:10.1007/s40744-017-0058-2 · Cited by 53
Lü, J., Shao, R.-H., Jin, S.-Y., Hu, L., Tu, Y., & Guo, J. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.11.010 · Cited by 49
Suicidal behavior in schizophrenia and depression: a comparison
Baca‐García, E., Pérez-Rodríguez, M. M., Díaz-Sastre, C., Sáiz, P. A., & de León, J. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.08.028 · Cited by 48 · cited 1×
“Depression causes deteriorated physical function, increased disability, and decreased quality of life(1,2) and leads to a significant increase in suicide risk.(3) According to statistics by the”
Chen, H. C., Spiers, J. G., Sernia, C., & Lavidis, N. A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.11.023 · Cited by 41
Laugeray, A., Launay, J.-M., Callebert, J., Mutlu, O., Guillemin, G. J., Belzung, C., & Barone, P. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164337 · Cited by 40
Luo, D., Ma, R., Wu, Y., Zhang, X., Liu, Y., Wang, L., & Fu, W. (2017) · Medical Science Monitor · doi:10.12659/msm.902549 · Cited by 35
Duan, D.-M., Tu, Y., Liu, P., & Jiao, S. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.193238 · Cited by 33
Wang, J., Hong, M., Chen, R., Ju, J., Peng, W., Zhang, G., & Liu, C. (2015) · Brain Research · doi:10.1016/j.brainres.2015.08.012 · Cited by 31
Zhang, Y., Qu, S., Zhang, J., Sun, Y.-L., Liu, W.-L., Xie, L., Huang, Y., & Chen, J. (2015) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2015.0114 · Cited by 27
Docherty, A. R., Edwards, A. C., Yang, F., Peterson, R. E., Sawyers, C., Adkins, D. E., Moore, A. A., Webb, B. T., Bacanu, S. A., Flint, J., et al. (2017) · Depression and Anxiety · doi:10.1002/da.22607 · Cited by 27
Chen, T., Xiong, Y. H., Long, M., Zheng, D., Ke, H., Xie, J., Yin, N., & Chen, Z. (2018) · Inflammation · doi:10.1007/s10753-018-0885-5 · Cited by 27
Naserzadeh, R., Abad, N., Ghorbanzadeh, B., Dolatshahi, M., & Mansouri, M. T. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.03.002 · Cited by 27
Deng, Y., Zhao, M., Xu, T., Jin-Hou, & Li, X. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0246-y · Cited by 24
Ramires, C. C., Longhi-Balbinot, D. T., Cidral‐Filho, F. J., Dias, D. V., dos Santos, A. R., & da Silva, M. D. (2020) · Acupuncture in Medicine · doi:10.1177/0964528420938379 · Cited by 23
Serum KIBRA mRNA and Protein Expression and Cognitive Functions in Depression
Talarowska, M. E., Szemraj, J., Kowalczyk, M., & Gałecki, P. (2016) · Medical Science Monitor · doi:10.12659/msm.895200 · Cited by 8
Research works printed but not linked: 4
- Yang, 2015, Neuropsychiatr Dis Treat, 11, 597
- Christmas, 2011, Neuropsychiatr Dis Treat, 7, 431
- Smith, 2018, Cochrane Database Syst Rev, 3, Cd004046
- Ramires, 2020, Acupunct Med, 964528420938379
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“…can both stimulate the KYN pathway and trigger TRP metabolism and subsequent synthesis of various TRYCATs, including the toxic NMDAR activator QUIN, 246 which in fl uences glutamate transmission, has a variety of immunomodulatory effects and has both neurotoxic and neuro-protective effects on the…”
BackgroundLi, N., Guo, Y., Gong, Y., Zhang, Y., Fan, W., Yao, K., Chen, Z., Dou, B., Lin, X., Chen, B., et al. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s341581 · Cited by 260
“It was reported that EA at GV29 and GV20 reduces IL-1β, IL-6, and TNF-α in the serum and hippocampus, restores the balanced expression between NMDAR subtypes, such as NR2B and NR2B, and produces an antidepressant effect.(79) The TRPV-1 channel in the brain is activated by ischemic stroke.”
BackgroundRevealing the magic of acupuncture based on biological mechanisms: A literature review
Zhang, B., Shi, H., Cao, S., Xie, L., Ren, P., Wang, J., & Shi, B. (2022) · BioScience Trends · doi:10.5582/bst.2022.01039 · Cited by 114
Estrogen-immuno-neuromodulation disorders in menopausal depression
Zhang, Y., Tan, X., & Tang, C. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03152-1 · Cited by 82
“E2 pretreatment can reduce the production of the above inflammatory factors and promote vascular repair pathway and no longer synthesizing 5-HT [80–82].”
BackgroundZhang, J., Zhang, N., Lei, J., Jing, B., Li, M., Tian, H., Xue, B., & Li, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109417 · Cited by 59
Metadata
- Authors
- Zhang, K., Liu, R., Gao, Y., Ma, W., & Shen, W.
- Affiliations
- Shanghai University of Traditional Chinese Medicine (CN)
- Corresponding author
- Shen, Weidong
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2020-10
- Volume
- Volume 16
- Pages
- 2257-2266
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- PMC
- PMC7547135
- OpenAlex
- W3091636698
- Cited by
- 39
- References
- 61
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 10 · 2023: 5 · 2022: 5 · 2021: 4
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- Science and Technology Commission of Shanghai Municipality (18401970600)
- Shanghai Municipal Health and Family Planning Commission (ZY(2018-2020)-CCCX-1005)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Complementary and alternative medicine › Acupuncture Treatment Research Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- electroacupuncture, depression-like behavior, lipopolysaccharide, neuroinflammation, indoleamine 2,3-dioxygenase, NMDA receptor, NR2B, kynurenine, quinolinic acid, serotonin, inflammatory cytokines, hippocampus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.